论文部分内容阅读
目的:评价富马酸比索洛尔(康忻,德国默克公司生产5MG/片)对慢性充血性心力衰竭患者的疗效。方法:研究我院收治的各种心血管疾病所致慢性心力衰竭患者80例,随机分为对照组和治疗组,各40例。经多普勒超声心动图检查评价患者用药前后各项指标及患者症状体征改善程度、血压、心率变化来评价比索洛尔对慢性充血性心力衰竭的疗效。结果:治疗组治疗后各项指标较治疗前明显改善(P<0.05,P<0.01),对照组治疗后各项指标较治疗前明显改善(P<0.05,P<0.01);2组治疗前比较,各项指标差异无统计学意义(P>0.05),2组治疗后比较,各项指标差异有统计学意义。(P<0.05)。尤其心率更明显。结论:比索洛尔能改善心力衰竭患者的左室功能和心室重构,并能有效控制心率和调节血压。患者对此药的耐受程度主要分布在5mg,为该药的常规剂量。
PURPOSE: To evaluate the efficacy of bisoprolol fumarate (Kang Xin, Merck, Germany, 5 mg / tablet) in patients with chronic congestive heart failure. Methods: 80 cases of chronic heart failure caused by various cardiovascular diseases admitted to our hospital were randomly divided into control group and treatment group, 40 cases each. Doppler echocardiography before and after evaluation of various indicators and patients with symptoms and signs of improvement, blood pressure, heart rate changes to evaluate bisoprolol in patients with chronic congestive heart failure. Results: After treatment, the indexes in the treatment group were significantly improved (P <0.05, P <0.01), while those in the control group were significantly improved after treatment (P <0.05, P <0.01) There was no significant difference among the indexes (P> 0.05). After treatment, the difference of each index was statistically significant. (P <0.05). In particular, heart rate is more obvious. Conclusion: Bisoprolol can improve left ventricular function and ventricular remodeling in patients with heart failure, and can effectively control heart rate and regulate blood pressure. Patient tolerance to this drug is mainly distributed in the 5mg, the conventional dose of the drug.